ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact of Depleting Induction Agents on BK Virus and Polyomavirus Associated Nephropathy

J. Clark1, A. Barlow1, A. Haririan2

1University of Maryland Medical Center, Baltimore, MD, 2University of Maryland School of Medicine, Baltimore, MD

Meeting: 2020 American Transplant Congress

Abstract number: C-206

Keywords: Kidney transplantation, Nephropathy, Polyma virus

Session Information

Session Name: Poster Session C: Kidney: Polyoma

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Polyomavirus associated nephropathy (PVAN) is an opportunistic infection associated with graft loss and rejection. Due to limited treatment options, identifying kidney transplant recipients at higher risk for developing PVAN is crucial to both early diagnosis and timely reductions of maintenance immunosuppression. While greater intensity immunosuppression has previously been associated with increased risk of polyomavirus, it remains unclear which immunosuppressive agents directly contribute to this risk. The purpose of this retrospective chart review is to assess if alemtuzumab, a monoclonal antibody with profound lymphocyte-depleting effect, accelerates time to BK virus replication or severity of PVAN among kidney transplant recipients compared to those who received rATG induction.

*Methods: We performed a retrospective chart review of kidney transplant recipients 18-80 years of age from August 2010-2019 who received depleting induction with subsequent biopsy confirmed PVAN and BK PCR viral loads >1,500 copies/mL.

*Results: There were 47 kidney transplant recipients identified who received depleting induction and later developed PVAN. Of these, 34 patients received alemtuzumab and 13 patients received rATG 6mg/kg (IBW). There were no differences in baseline characteristics between those who received alemtuzumab compared to rATG induction. Maintenance immunosuppression at the time of BK virus diagnosis did not differ between groups. [Table 1] Patients who received alemtuzumab induction did not develop BK virus at a faster rate than those who received rATG induction (211 days vs. 260 days, p=0.248). PVAN was not more severe in the alemtuzumab group, defined by no differences in polyomavirus pattern (p=0.2), SV40% (p=0.468), interstitial fibrosis, or tubular atrophy (p=0.864).

*Conclusions: Alemtuzumab was not observed to be associated with an accelerated rate of developing BK virus or increased severity of PVAN when compared to rATG induction.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Clark J, Barlow A, Haririan A. Impact of Depleting Induction Agents on BK Virus and Polyomavirus Associated Nephropathy [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-depleting-induction-agents-on-bk-virus-and-polyomavirus-associated-nephropathy/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences